[Allergic risk and role of the Allergy Vigilance Network].
The recent increase in the incidence of severe anaphylaxis calls for continual assessment of risk factor and dangers associated with food allergy, keeping abreast of changes in the food industry. Allergologists, regulatory bodies and the food industry are all responsible for food safety. The Allergy Vigilance Network, founded by a university research team and comprising 398 French and Belgian allergologists, has developed a three-point strategy. First, reporting cases of severe anaphylaxis of document allergic origin makes it possible to monitor the prevalence of food allergens and to evaluate the quality of management of allergy-related emergencies, thus providing data suitable for estimating the economic burden of anaphylaxis. The second objective of the network is to set up multicenter trials to determine the prevalence of sensitization to risk allergens, such as peanut, lupin and plant pollen, of which transgenic varieties will soon emerge. The third objective is screening and long-term monitoring of dangers related to new foods, ingredients and adjuvant sensitizing factors. Post-marketing monitoring of potential allergic risks arising from genetically modified food is another aim of the network, together with the establishment of a serum bank, following WHO/FAO recommendations. The Allergy Vigilance Network, together with the French National Institute for Food Safety (AFSSA), the Ministry of Consumer Affairs (DGCCRF) and various patient associations, is striving to analyse and deal with dangers related to the allergenicity of natural and modified food proteins.
Moneret-Vautrin
Denise-Anne
DA
Médecine interne, immunologie clinique et allergologique, Hôpital Central, 54035 Nancy cedex.
D000707:Anaphylaxis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D001530:Belgium; D005502:Food / Q000592:standards; D005512:Food Hypersensitivity / Q000453:epidemiology / Q000517:prevention & control*; D030841:Food, Genetically Modified / Q000009:adverse effects; D005602:France; D006306:Health Surveys; D006801:Humans; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D012308:Risk Management; D012449:Safety; D014944:World Health Organization